Serafini Steven, O'Flaherty Cristian
Experimental Medicine Division, Department of Medicine, McGill University, Montréal, QC, Canada.
Urology Division, Department of Surgery, McGill University, Montréal, QC, Canada.
Hum Reprod. 2025 Feb 1;40(2):210-225. doi: 10.1093/humrep/deae268.
What role do sphingolipids have in mediating human sperm capacitation?
Sphingosine 1-phosphate (S1P) mediates the acquisition of fertilizing competency in human spermatozoa by engaging with its Gi-coupled receptor S1PR1 and promoting production of reactive oxygen species such as nitric oxide and superoxide anion.
Bioactive sphingolipids, such as S1P, are fundamental for regulating numerous physiological domains and processes, such as cell membranes and signalling, cell death and proliferation, cell migration and invasiveness, inflammation, and central nervous system development.
STUDY DESIGN, SIZE, DURATION: Semen samples were obtained from a cohort of 10 healthy non-smoking volunteers (18-30 years old) to investigate the role of S1P in sperm.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Percoll-selected human spermatozoa were incubated at 37°C for 3.5 h in BWW media with or without foetal cord serum ultrafiltrate (FCSu), sphingosine (Sph), or ceramide (Cer). Spermatozoa were also incubated with or without pharmacological inhibitors of sphingolipid metabolism. Protein tyrosine phosphorylation was determined by immunoblotting. The acrosome reaction was determined by PSA-FTIC labelling of the acrosome and analysed using fluorescence microscopy. Intracellular nitric oxide (NO•) production was determined using a DAF-2DA probe. Immunocytochemistry was performed to localize and assess the functional relationship of key components of lipid signalling in spermatozoa. Sperm viability and motility of the samples were evaluated by the hypo-osmotic swelling (HOS) test and computer-aided sperm analysis (CASA). Statistical differences between groups were determined using ANOVA and Tukey's test. Normal distribution of the data and variance homogeneity were assessed using Shapiro-Wilk and Levene's test, respectively. A difference was considered significant when the P-value was ≤0.05.
S1P mediates the acquisition of fertilizing competency in human spermatozoa by engaging with its Gi-coupled receptor S1PR1. We found that S1PR1 redistributes to the post-acrosomal region upon induction of capacitation. S1P signalling promotes the activation of the PI3K-AKT pathway, leading to NO• production during sperm capacitation. L-NAME, an nitric oxide synthase inhibitor, impaired the Sph- and Cer-dependent capacitation. Additionally, Sph and Cer promote superoxide anion (O2•-) production, and the extracellular addition of superoxide dismutase (SOD) prevented Sph- and Cer-dependent capacitation, suggesting that Sph and Cer stimulate O2•- production during sperm capacitation. Protein kinase type R (PKR), ceramide kinase (CERK), and protein kinase C (PKC) are responsible for translocating and activating sphingosine kinase 1 (SphK1), which is necessary to promote S1P production for sperm capacitation.
N/A.
LIMITATIONS, REASONS FOR CAUTION: The utilization and actions of sphingolipids may differ in spermatozoa of different species.
Sphingolipid metabolites such as Sph, Cer, S1P, and ceramide 1-phosphate (C1P) play a crucial role in inducing human sperm capacitation. Our research has provided new insights into fundamental sphingolipid processes in human sperm, including the importance of C1P in translocating and activating SphK1 as well as the S1P signalling to regulate the PI3K/AKT/NOS pathway to generate NO• for sperm capacitation. We are the first to identify the presence of PKR in human spermatozoa and its role in the phosphorylation activities of SphK1 with the subsequent activation of S1P signalling. Furthermore, our study has identified that S1PR1 and S1PR3 are involved in capacitation and the acrosome reaction, respectively. These findings shed light on a novel mechanism by which sphingolipids drive capacitation in human sperm and pave the way for further exploration of the role of bioactive sphingolipid metabolites in this process. Lastly, our studies lay the foundation for examining the lipid profile of infertile males, as potential discrepancies can affect the functional capacity of spermatozoa to reach fertilizing potential.
STUDY FUNDING/COMPETING INTEREST(S): This research was funded by the Canadian Institutes of Health Research (CIHR), grant number PJT-165962 to C.O.F. S.S. was awarded a Research Institute-MUHC Desjardins Studentship. There are no competing interests to report.
鞘脂在介导人类精子获能过程中起什么作用?
1-磷酸鞘氨醇(S1P)通过与Gi偶联受体S1PR1结合并促进活性氧如一氧化氮和超氧阴离子的产生,介导人类精子获得受精能力。
生物活性鞘脂,如S1P,对于调节众多生理领域和过程至关重要,如细胞膜和信号传导、细胞死亡与增殖、细胞迁移与侵袭、炎症以及中枢神经系统发育。
研究设计、规模、持续时间:从一组10名健康非吸烟志愿者(18 - 30岁)中获取精液样本,以研究S1P在精子中的作用。
参与者/材料、设置、方法:将经Percoll梯度离心法筛选的人类精子在37°C下于含或不含胎牛血清超滤物(FCSu)、鞘氨醇(Sph)或神经酰胺(Cer)的BWW培养基中孵育3.5小时。精子还分别在有或没有鞘脂代谢的药理学抑制剂的情况下孵育。通过免疫印迹法测定蛋白质酪氨酸磷酸化。通过顶体蛋白酶 - 荧光素异硫氰酸酯(PSA - FTIC)标记顶体来确定顶体反应,并使用荧光显微镜进行分析。使用DAF - 2DA探针测定细胞内一氧化氮(NO•)的产生。进行免疫细胞化学以定位和评估精子中脂质信号关键成分的功能关系。通过低渗肿胀试验(HOS)和计算机辅助精子分析(CASA)评估样本的精子活力和运动能力。使用方差分析(ANOVA)和Tukey检验确定组间的统计学差异。分别使用Shapiro - Wilk检验和Levene检验评估数据的正态分布和方差齐性。当P值≤0.05时,差异被认为具有统计学意义。
S1P通过与Gi偶联受体S1PR1结合介导人类精子获得受精能力。我们发现,在获能诱导后,S1PR1重新分布到顶体后区域。S1P信号传导促进PI3K - AKT途径的激活,导致精子获能过程中产生NO•。一氧化氮合酶抑制剂L - NAME损害了Sph和Cer依赖性获能。此外,Sph和Cer促进超氧阴离子(O2•-)的产生,并且细胞外添加超氧化物歧化酶(SOD)可阻止Sph和Cer依赖性获能,这表明Sph和Cer在精子获能过程中刺激O2•-的产生。蛋白激酶R型(PKR)、神经酰胺激酶(CERK)和蛋白激酶C(PKC)负责转运和激活鞘氨醇激酶1(SphK1),这是促进精子获能所需的S1P产生所必需的。
无。
局限性、谨慎原因:鞘脂在不同物种精子中的利用和作用可能不同。
鞘脂代谢产物如Sph、Cer、S1P和1 - 磷酸神经酰胺(C1P)在诱导人类精子获能中起关键作用。我们的研究为人类精子中基本的鞘脂过程提供了新的见解,包括C1P在转运和激活SphK1以及S1P信号传导以调节PI3K / AKT / NOS途径以产生用于精子获能的NO•方面的重要性。我们是首个鉴定出人类精子中存在PKR及其在SphK1磷酸化活性以及随后激活S1P信号传导中的作用的研究。此外,我们的研究确定S1PR1和S1PR3分别参与获能和顶体反应。这些发现揭示了鞘脂驱动人类精子获能的新机制,并为进一步探索生物活性鞘脂代谢产物在此过程中的作用铺平了道路。最后,我们的研究为检查不育男性的脂质谱奠定了基础,因为潜在的差异可能影响精子达到受精潜力的功能能力。
研究资金/利益冲突:本研究由加拿大卫生研究院(CIHR)资助,编号为PJT - 165962,授予C.O.F.。S.S.获得了麦吉尔大学健康中心研究所 - 德斯贾丁斯学生奖学金。无利益冲突需要申报。